• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于补充医学中作为抗病毒药物的植物材料中对抗新冠病毒感染的强效植物化学物质:综述

Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review.

作者信息

Sharanya C S, Sabu A, Haridas M

机构信息

Inter University Centre for Bioscience and Department of Biotechnology & Microbiology, Dr. Janaki Ammal Campus, Kannur University, Thalassery, 670661 India.

出版信息

Futur J Pharm Sci. 2021;7(1):113. doi: 10.1186/s43094-021-00259-7. Epub 2021 Jun 2.

DOI:10.1186/s43094-021-00259-7
PMID:34095323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8170460/
Abstract

BACKGROUND

Following the outbreak of the COVID-19 pandemic, there was a surge of research activity to find methods/drugs to treat it. There has been drug-repurposing research focusing on traditional medicines. Concomitantly, many researchers tried to find in silico evidence for traditional medicines. There is a great increase in article publication to commensurate the new-found research interests. This situation inspired the authors to have a comprehensive understanding of the multitude of publications related to the COVID-19 pandemic with a wish to get promising drug leads.

MAIN BODY

This review article has been conceived and made as a hybrid of the review of the selected papers advertised recently and produced in the interest of the COVID-19 situation, and in silico work done by the authors. The outcome of the present review underscores a recommendation for thorough MDS analyses of the promising drug leads. The inclusion of in silico work as an addition to the review was motivated by a recently published article of Toelzer and colleagues. The in silico investigation of free fatty acids is novel to the field and it buttresses the further MDS analysis of drug leads for managing the COVID-19 pandemic.

CONCLUSION

The review performed threw light on the need for MDS analyses to be considered together with the application of other in silico methods of prediction of pharmacologic properties directing towards the sites of drug-receptor regulation. Also, the present analysis would help formulate new recipes for complementary medicines.

摘要

背景

新型冠状病毒肺炎疫情爆发后,为寻找治疗方法/药物的研究活动激增。出现了针对传统药物的药物再利用研究。与此同时,许多研究人员试图寻找传统药物的计算机模拟证据。相关文章的发表量大幅增加,以契合新出现的研究兴趣。这种情况促使作者全面了解与新型冠状病毒肺炎疫情相关的大量出版物,以期获得有前景的药物先导物。

主体

这篇综述文章的构思和撰写结合了近期为应对新型冠状病毒肺炎疫情而发表的精选论文综述以及作者所做的计算机模拟工作。本次综述的结果强调了对有前景的药物先导物进行全面分子对接模拟(MDS)分析的建议。将计算机模拟工作纳入综述是受特尔泽尔及其同事最近发表的一篇文章的启发。对游离脂肪酸的计算机模拟研究在该领域是新颖的,它为管理新型冠状病毒肺炎疫情的药物先导物的进一步分子对接模拟分析提供了支持。

结论

本次综述揭示了将分子对接模拟分析与其他预测药物性质的计算机模拟方法结合应用于药物 - 受体调控位点研究的必要性。此外,当前的分析将有助于制定补充药物的新配方。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/99bc245cef52/43094_2021_259_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/caa5b0d2a05b/43094_2021_259_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/56395be62867/43094_2021_259_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/518b38be8212/43094_2021_259_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/9effd983a470/43094_2021_259_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/95b65eca88d3/43094_2021_259_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/1bcce4d32740/43094_2021_259_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/99bc245cef52/43094_2021_259_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/caa5b0d2a05b/43094_2021_259_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/56395be62867/43094_2021_259_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/518b38be8212/43094_2021_259_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/9effd983a470/43094_2021_259_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/95b65eca88d3/43094_2021_259_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/1bcce4d32740/43094_2021_259_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/010c/8170460/99bc245cef52/43094_2021_259_Fig7_HTML.jpg

相似文献

1
Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review.用于补充医学中作为抗病毒药物的植物材料中对抗新冠病毒感染的强效植物化学物质:综述
Futur J Pharm Sci. 2021;7(1):113. doi: 10.1186/s43094-021-00259-7. Epub 2021 Jun 2.
2
Phytomedicines explored under and studies against coronavirus: An opportunity to develop traditional medicines.在[具体研究条件1]和[具体研究条件2]下探索的抗冠状病毒植物药:开发传统药物的契机。
S Afr J Bot. 2022 Dec;151:451-483. doi: 10.1016/j.sajb.2022.04.053. Epub 2022 May 2.
3
In Silico Studies Reveal Antiviral Effects of Traditional Indian Spices on COVID-19.计算机模拟研究揭示了印度传统香料对新冠病毒的抗病毒作用。
Curr Pharm Des. 2021;27(32):3462-3475. doi: 10.2174/1381612826666201223095548.
4
validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.验证香豆素衍生物作为潜在抑制剂对 SARS-CoV-2 的主要蛋白酶、NSP10/NSP16-甲基转移酶、磷酸酶和内切核糖核酸酶的抑制作用。
J Biomol Struct Dyn. 2021 Nov;39(18):7306-7321. doi: 10.1080/07391102.2020.1808075. Epub 2020 Aug 24.
5
Evidence-based traditional Siddha formulations for prophylaxis and management of respiratory symptoms in COVID-19 pandemic-a review.基于循证的悉达传统配方在新冠疫情中对呼吸道症状的预防和管理——综述
Biocatal Agric Biotechnol. 2021 Aug;35:102056. doi: 10.1016/j.bcab.2021.102056. Epub 2021 Jun 7.
6
A Systematic Review on the Contribution of Artificial Intelligence in the Development of Medicines for COVID-2019.关于人工智能在2019年冠状病毒病药物研发中作用的系统评价
J Pers Med. 2021 Sep 18;11(9):926. doi: 10.3390/jpm11090926.
7
Traditional Indian medicine in China: The status quo of recognition, development and research.中国传统医学:认同、发展与研究现状。
J Ethnopharmacol. 2021 Oct 28;279:114317. doi: 10.1016/j.jep.2021.114317. Epub 2021 Jun 8.
8
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.基于药物再利用的分子对接和动力学模拟预测 SARS-CoV-2 主要蛋白酶的潜在抑制剂的计算机预测。
J Infect Public Health. 2020 Sep;13(9):1210-1223. doi: 10.1016/j.jiph.2020.06.016. Epub 2020 Jun 16.
9
In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (M) and spike (S) receptor.以环糊精包合物作为潜在抑制剂针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶(M)和刺突蛋白(S)受体的药用植物的计算机模拟研究。
Inform Med Unlocked. 2021;25:100645. doi: 10.1016/j.imu.2021.100645. Epub 2021 Jun 24.
10
Phytochemical Moieties From Indian Traditional Medicine for Targeting Dual Hotspots on SARS-CoV-2 Spike Protein: An Integrative Approach.源自印度传统医学的植物化学成分靶向新冠病毒刺突蛋白上的两个热点:一种综合方法
Front Med (Lausanne). 2021 May 7;8:672629. doi: 10.3389/fmed.2021.672629. eCollection 2021.

引用本文的文献

1
Ethnopharmacological Potential of Phytochemicals and Phytogenic Products against Human RNA Viral Diseases as Preventive Therapeutics.植物化学物质和植物源产品防治人类 RNA 病毒病的民族药理学潜力:预防治疗方法。
Biomed Res Int. 2023 Feb 20;2023:1977602. doi: 10.1155/2023/1977602. eCollection 2023.
2
Efficacy of polyherbal formulations for prevention of COVID-19 infection in high-risk subjects: A randomized open-label controlled clinical trial.多草药配方预防高危人群 COVID-19 感染的疗效:一项随机、开放标签、对照临床试验。
Phytother Res. 2022 Sep;36(9):3632-3643. doi: 10.1002/ptr.7531. Epub 2022 Jul 5.
3
Role of Diet and Nutrients in SARS-CoV-2 Infection: Incidence on Oxidative Stress, Inflammatory Status and Viral Production.

本文引用的文献

1
Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity.氯喹重新用于治疗多种疾病,特别关注严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及相关毒性。
Front Pharmacol. 2021 Apr 12;12:576093. doi: 10.3389/fphar.2021.576093. eCollection 2021.
2
Compounds of and for COVID-19 inhibition: in silico evidence for cues from Ayurveda.用于抑制新型冠状病毒肺炎的[具体物质1]和[具体物质2]化合物:来自阿育吠陀医学线索的计算机模拟证据
Futur J Pharm Sci. 2021;7(1):13. doi: 10.1186/s43094-020-00171-6. Epub 2021 Jan 9.
3
Impact of repurposed drugs on the symptomatic COVID-19 patients.
饮食和营养在 SARS-CoV-2 感染中的作用:对氧化应激、炎症状态和病毒产生的影响。
Nutrients. 2022 May 25;14(11):2194. doi: 10.3390/nu14112194.
重新利用药物对有症状的 COVID-19 患者的影响。
J Infect Public Health. 2021 Jan;14(1):24-38. doi: 10.1016/j.jiph.2020.11.009. Epub 2020 Dec 7.
4
Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach.采用计算机模拟方法评价传统阿育吠陀卡达预防和管理新型冠状病毒(SARS-CoV-2)。
J Biomol Struct Dyn. 2022 Jun;40(9):3949-3964. doi: 10.1080/07391102.2020.1852119. Epub 2020 Nov 30.
5
Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.潜在植物化学物质的分子对接研究及其对 SARS-CoV2 刺突蛋白和人 ACE2 复合物的影响。
Sci Rep. 2020 Oct 19;10(1):17699. doi: 10.1038/s41598-020-74715-4.
6
Characteristics of SARS-CoV-2 and COVID-19.SARS-CoV-2 和 COVID-19 的特征。
Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6.
7
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study.长期使用羟氯喹治疗风湿性疾病患者与感染严重急性呼吸综合征冠状病毒2的相关性:一项回顾性队列研究
Lancet Rheumatol. 2020 Nov;2(11):e689-e697. doi: 10.1016/S2665-9913(20)30305-2. Epub 2020 Sep 21.
8
Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.氯喹和羟氯喹治疗 COVID-19:重新利用失败的观点。
J Clin Pharm Ther. 2021 Feb;46(1):17-27. doi: 10.1111/jcpt.13267. Epub 2020 Sep 27.
9
Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.新冠病毒 Spike 蛋白锁闭结构中的游离脂肪酸结合口袋。
Science. 2020 Nov 6;370(6517):725-730. doi: 10.1126/science.abd3255. Epub 2020 Sep 21.
10
Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.一种广谱抗冠状病毒药物对SARS-CoV-2主要蛋白酶的抑制作用的结构基础
Am J Cancer Res. 2020 Aug 1;10(8):2535-2545. eCollection 2020.